Cargando…

Primary malignant melanoma of the male urethra: a case report

We present a rare case of a 69-year-old male patient with serendipitous urethral melanoma. He complained of dysuria and recurrent urinary retention and was initially diagnosed with benign prostatic hyperplasia. Accidentally, a dark-brown pigmented macula was found in the distal urethra at the end of...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Liqun, Liu, Sanhe, Li, Yongzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798279/
https://www.ncbi.nlm.nih.gov/pubmed/35116351
http://dx.doi.org/10.21037/tcr-21-1150
_version_ 1784641763579789312
author Duan, Liqun
Liu, Sanhe
Li, Yongzhi
author_facet Duan, Liqun
Liu, Sanhe
Li, Yongzhi
author_sort Duan, Liqun
collection PubMed
description We present a rare case of a 69-year-old male patient with serendipitous urethral melanoma. He complained of dysuria and recurrent urinary retention and was initially diagnosed with benign prostatic hyperplasia. Accidentally, a dark-brown pigmented macula was found in the distal urethra at the end of transurethral prostatectomy when we exited the resectoscope, transurethral resection of the nidus and sent to pathological examination showed the characteristics of melanoma. No other lesions were found on further examination and the patient preferred a close follow-up cystoscopy rather than an immediate urethrectomy. Unsurprisingly, he relapsed in the urethra with the local disease three months later and we treated him with partial urethrectomy, followed by watchful waiting for 11 months. However, the patient was readmitted for hematuria, and (18)F-FDG PET-CT showed a large number of pelvic and bone metastatic lesions. Therefore, eight cycles of single-agent dacarbazine chemotherapy were administered, and the disease was demonstrated prolonged stabilization. Follow-up was conducted every 3 months, during which time palliative transurethral resection of the melanoma in the bladder was performed to control urinary tract infections. Although the prognosis of the disease is extremely poor, this patient has gained more than 50 months of overall survival and is alive to date.
format Online
Article
Text
id pubmed-8798279
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87982792022-02-02 Primary malignant melanoma of the male urethra: a case report Duan, Liqun Liu, Sanhe Li, Yongzhi Transl Cancer Res Case Report We present a rare case of a 69-year-old male patient with serendipitous urethral melanoma. He complained of dysuria and recurrent urinary retention and was initially diagnosed with benign prostatic hyperplasia. Accidentally, a dark-brown pigmented macula was found in the distal urethra at the end of transurethral prostatectomy when we exited the resectoscope, transurethral resection of the nidus and sent to pathological examination showed the characteristics of melanoma. No other lesions were found on further examination and the patient preferred a close follow-up cystoscopy rather than an immediate urethrectomy. Unsurprisingly, he relapsed in the urethra with the local disease three months later and we treated him with partial urethrectomy, followed by watchful waiting for 11 months. However, the patient was readmitted for hematuria, and (18)F-FDG PET-CT showed a large number of pelvic and bone metastatic lesions. Therefore, eight cycles of single-agent dacarbazine chemotherapy were administered, and the disease was demonstrated prolonged stabilization. Follow-up was conducted every 3 months, during which time palliative transurethral resection of the melanoma in the bladder was performed to control urinary tract infections. Although the prognosis of the disease is extremely poor, this patient has gained more than 50 months of overall survival and is alive to date. AME Publishing Company 2021-11 /pmc/articles/PMC8798279/ /pubmed/35116351 http://dx.doi.org/10.21037/tcr-21-1150 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Case Report
Duan, Liqun
Liu, Sanhe
Li, Yongzhi
Primary malignant melanoma of the male urethra: a case report
title Primary malignant melanoma of the male urethra: a case report
title_full Primary malignant melanoma of the male urethra: a case report
title_fullStr Primary malignant melanoma of the male urethra: a case report
title_full_unstemmed Primary malignant melanoma of the male urethra: a case report
title_short Primary malignant melanoma of the male urethra: a case report
title_sort primary malignant melanoma of the male urethra: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798279/
https://www.ncbi.nlm.nih.gov/pubmed/35116351
http://dx.doi.org/10.21037/tcr-21-1150
work_keys_str_mv AT duanliqun primarymalignantmelanomaofthemaleurethraacasereport
AT liusanhe primarymalignantmelanomaofthemaleurethraacasereport
AT liyongzhi primarymalignantmelanomaofthemaleurethraacasereport